Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 492 results for "ranbaxy lab"

Pharma shares on roll; CNX Pharma index hits new high
Business Standard

Pharma shares on roll; CNX Pharma index hits new high

Pharma, Ranbaxy Lab, Aurobindo, Glenmark Pharma, Strides Arcolab, Divi's Lab, Lupin and Cipla are up 1-6% on SI Reporter | Mumbai September 29, 2014 Last Updated at 11:00 IST Shares of pharmaceutical companies are on a roll with most of the frontline stocks ... Business Standard, 1 day ago
Pharma shares in demand; Healthcare index hits new high Business Standard, 2 months ago
Sun Pharma up 4% on likely USFDA relief Times of India, 4 days ago

19 images for ranbaxy lab

Financial Express, 1 week ago
Financial Express, 1 month ago
VC Circle, 2 months ago
Livemint.com, 2 months ago
American Banking News, 4 months ago
Rediff.com, 3 months ago
Sify, 4 months ago
Rediff.com, 3 months ago
Rediff.com, 3 months ago
Yahoo! News Australia, 4 months ago

Hold Ranbaxy Lab; target Rs 750-770: Akshata Deshmukh

Akshata Deshmukh, Chief Strategist-Trading at Networth Stock Broking is of the view that one may hold Ranbaxy Laboratories with a target of Rs 750-770.
 Money Control1 month ago Bull's Eye: Buy Lupin, HDFC; short HDIL, Reliance Capital  Money Control1 week ago Hold Ranbaxy Labs; target of Rs 615: KRChoksey  Money Control1 month ago Buy Ranbaxy Labs; target of Rs 605: Motilal Oswal  Money Control2 months ago

More exits from Ranbaxy Lab's top management team

With the fresh exits, nearly half of the members who were part of Ranbaxy’s executive committee two years ago will no longer be part of the team. NEW DELHI: Ranbaxy Laboratories' global HR head Sandeep Girotra has stepped down while its president of ...
 Economic Times1 month ago
4 Traders

Sun Pharma's Ranbaxy deal on course, hints at more acquisitions

Sun Pharmaceutical Industries, India's largest drugmaker by market value, said it is in the process of acquiring Ranbaxy Lab from Japan's Daiichi Sankyo, and is open for more acquisitions. "Till the time we are able to integrate Ranbaxy ...
 DNA India1 month ago Sun's Ranbaxy deal on course, hints at more  4 Traders1 month ago

Ranbaxy Lab allots equity shares

Ranbaxy Laboratories announced that the ESOPs allotment committee of directors has allotted 207,529 equity shares on exercise of stock options under the Employees Stock Option Scheme(s) of the company. The paid-up equity share capital of the company post ...
 Myiris2 months ago
Money Today

Bull run: Almost 450 stocks hit 52-week highs on BSE

A total of 447 stocks touched their 52-week highs on the BSE, including Lupin, Ranbaxy Lab, Strides Arcolab, Sun Pharma, Tata Motors, Tech Mahindra and TVS Motor. The S&P BSE Sensex closed at 25,823.75, down 17.46 points from Wednesday's close, after hitting ...
 Money Today2 months ago

Ranbaxy Lab receives Civil Investigative Demand from United States Department of Justice

The CID is a request for documents and information, and is not an allegation of wrongdoing or demand for compensation. Ranbaxy Laboratories Ltd has announced that the Company has received a Civil Investigative Demand ("CID") from the United States Department ...
 India Infoline1 week ago Ranbaxy Labs. - Receipt of Civil Investigative Demand ("CID"...  SBICAP Securities1 week ago Ranbaxy Labs. - Communication received from the Competition...  SBICAP Securities1 month ago
Moneycontrol.com

Ranbaxy Laboratories' Q2 results on October 28, 2014

Ranbaxy Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on October 28, 2014, inter alia, to consider and approve Standalone and Consolidated Unaudited Financial Results for the second quarter ...
 Moneycontrol.com1 day ago Price cuts announced by NPPA to hit Ranbaxy, Cipla the most  Economic Times1 week ago Angel Broking remains neutral on Ranbaxy Labs  MyIris2 weeks ago Epirus, Ranbaxy win India approval for arthritis drug copy  Moneycontrol.com2 weeks ago
[x]  
NDTV Profit

Angel Broking maintains ''Neutral'' on Sun Pharma

Sun Pharmaceuticals plans to focus on dermatology, post its merger with Ranbaxy Labs, expected to be completed by 2014. The company has lined-up a strategy to make dermatology its biggest segment and expects almost 38-40% of US sales to come from ...
 MyIris1 day ago Sun Pharma stock price reacts on news of US FDA's surprise plant inspection  The Hindu2 weeks ago Sun Pharma falls 6% as USFDA inspects Halol unit; facility contributes 40% of US sales  Economic Times2 weeks ago Angel Broking maintains neutral on Sun Pharma  MyIris2 weeks ago

Ranbaxy Laboratories: Outcome of court convened meeting of equity shareholders

Ranbaxy Laboratories Ltd has informed BSE regarding "Court Convened Meeting of Equity Shareholders of the Company held on September 19, 2014".Source : BSE Read all announcements in Ranbaxy Labs To read the full report
 Moneycontrol.com6 days ago Ranbaxy Labs. - Court Convened Meeting of the Equity Shareho...  SBICAP Securities1 month ago Ranbaxy Labs' court convened meeting on Sept 19, 2014  Money Control1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less